iShares US Pharma
IHE----
MSD’s Keytruda and Padcev combination receives EC approval
Pharmaceutical Technology·Pfizer (NYSE:PFE) Shares Climb 1.8% - Still a Buy?
Market Beat·- Pfizer Inc. shares rose 1.8% to trade at $30.3950, with a market capitalization of $173.24 billion. - Several financial institutions and research analysts have adjusted their ratings and price targets for the biopharmaceutical company. - The company previously reported a quarterly EPS of $0.77 and revenue of $15.03 billion, alongside a declared quarterly dividend of $0.43 per share.